ANTONAZZO IPPAZIO COSIMO

Mazzaglia, G., Antonazzo, I., Mol, P. (2024). Risk management and drug utilization research. In Drug Utilization Research: Methods and Applications (pp. 428-436). wiley [10.1002/9781119911685.ch42]. Detail

Antonazzo, I., Cortesi, P., Zanon, E., Pasca, S., Morfini, M., Santoro, C., et al. (2024). Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients. MEDICINA, 60(1) [10.3390/medicina60010034]. Detail

Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2024). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA [10.1007/s00592-024-02359-1]. Detail

Ferrara, P., Antonazzo, I., Zamparini, M., Fornari, C., Borrelli, C., Boarino, S., et al. (2024). Epidemiology of SLE in Italy: an observational study using a primary care database. LUPUS SCIENCE & MEDICINE, 11(1) [10.1136/lupus-2024-001162]. Detail

Fornari, A., Antonazzo, I., Rocino, A., Preti, D., Fragomeno, A., Cucuzza, F., et al. (2024). The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey. HAEMOPHILIA, 30(2), 449-462 [10.1111/hae.14926]. Detail